American Conference on Pharmacometrics (ACoP) 2026 Conference
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 611430 Professional and Management Development Training
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring attendance and participation support for the American Conference on Pharmacometrics (ACoP) 2026 Conference, a leading scientific meeting focused on pharmacometrics and quantitative pharmacology. The engagement provides FDA staff access to emerging scientific approaches in model-informed drug development, direct engagement with experts across industry, academia, and regulatory agencies, and practical knowledge and tools to support organizational goals and regulatory innovation. The estimated solicitation release date is August 1, 2026, with an estimated award date of October 1, 2026.
The estimated award value ranges from $25,000 to $250,000. The contact for inquiries is the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
ACop Conference is widely recognized as the leading scientific meeting for pharmacometrics and quantitative pharmacology. Attending provides insights into emerging scientific approaches that will directly benefit current and upcoming projects; allow engagement with experts across industry, academia, and regulatory agencies; bring back practical knowledge, tools, and connections to support FDA organizational goals and allows attendees to stay at the forefront of innovation in model-informed drug development
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast